TERRY WHITE CHEMISTS SITAGLIPTIN sitagliptin 50 mg (as phosphate monohydrate) tablet blister pack

Land: Australien

Sprog: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv bestanddel:

sitagliptin phosphate monohydrate, Quantity: 64.25 mg (Equivalent: sitagliptin, Qty 50 mg)

Tilgængelig fra:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

sitagliptin phosphate monohydrate

Lægemiddelform:

Tablet

Sammensætning:

Excipient Ingredients: hyprolose; croscarmellose sodium; calcium hydrogen phosphate; iron oxide yellow; magnesium stearate; titanium dioxide; iron oxide red; macrogol 8000; purified talc; hypromellose; microcrystalline cellulose

Indgivelsesvej:

Oral

Enheder i pakken:

28

Recept type:

(S4) Prescription Only Medicine

Terapeutiske indikationer:

Sitagliptin is indicated for the treatment of diabetes mellitus type 2 in persons 18 years of age and older who have failed dietary measures and exercise:,- as monotherapy, as an adjunct to diet and exercise to improve glycaemic control in patients with type 2 diabetes mellitus, when metformin cannot be used.,- as dual combination therapy, with metformin, or with a sulfonylurea, or with a thiazolidinedione where the use of a thiazolidinedione is considered appropriate.,- as triple combination therapy with metformin and a sulfonylurea when combination therapy with both agents does not provide adequate glycaemic control.,- as add-on combination therapy with insulin (with or without metformin).

Produkt oversigt:

Visual Identification: Light beige, round, biconvex coated tablet. Engraved "SIT" over "50" on one side and "APO" on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius

Autorisation status:

Licence status A

Autorisation dato:

2015-04-15